In this essay I want to explore the problems that surround the concept of shareholder value and its maximization.
30-day returns
James Montier is a member of GMO's asset allocation team. Prior to that, he was the co-Head of Global.
Independent Consultant · Experience: Self-employed · Education: University of Portsmouth · Location: Greater London · 500+ connections on LinkedIn.
James Montier
Author
James Montier is a member of GMO's asset allocation team. Prior to that, he was the co-Head of Global Strategy at Société Générale and has been the top-rated strategist in the annual Thomson Extel survey for most of the last decade. ... Google Books
Books
The Little Book of Behavioral Investing: How Not to be Your Own Worst Enemy
2010
Behavioural Investing: A Practitioner's Guide to Applying Behavioural Finance
2007
Value Investing: Tools and Techniques for Intelligent Investment
2009
Behavioural Finance: Insights Into Irrational Minds and Markets
2002
Selected Essays on Value Investing
2010
James Montier, GMO. James is a member of GMO's Asset Allocation team. Prior to joining GMO in 2009, he was co-head of Global Strategy at Société Générale.
In this paper, James Montier presents a set of principles that together form what he calls “The Seven Immutable Laws of Investing.”
James Montier is an expert in behavioral finance, argues that investors would have a greater chance of spotting the formation of bubbles if they could only ...
919K · Free 5–8 day delivery over $15 · Free 30-day returns
Looking for books by James Montier? See all books authored by James Montier, including The Little Book of Behavioral Investing: How Not to Be Your Own Worst ...
Rating
(810) · 30-day returns
James Montier is a member of GMO's asset allocation team. Prior to that, he was the co-Head of Global Strategy at Société Générale and has been the top-rated ...
During this interview with Schroders, James Montier explains why value investing provides behavioral self-defence. Here's an excerpt from the interview: ...
Sep 25, 2023 · In addition to being an author, James is a member of GMO's asset allocation team and a partner at the firm. Previous to his tenure at GMO, he ...